[Cutaneous zygomycosis due to Absidia corymbifera].
Govaert
J C
JC
Bergman
W
W
van het Wout
J
J
D020095:Absidia / Q000302:isolation & purification*; D000368:Aged; D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005499:Folliculitis / Q000382:microbiology; D006801:Humans; D008297:Male; D009091:Mucormycosis / Q000382:microbiology; D012871:Skin Diseases / Q000188:drug therapy / Q000382:microbiology*; D020096:Zygomycosis / Q000188:drug therapy / Q000382:microbiology*
D000935:Antifungal Agents; D000666:Amphotericin B